Dr. Lori Ann White, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 4132 Erie St Ste 208, Willoughby, OH 44094 Phone: 440-946-7796 Fax: 440-946-7796 |
Ms. Kathy Whan-marko, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3951 Erie St, #208, Willoughby, OH 44094 Phone: 440-918-1540 |
Dr. Richard Alan Brunner, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 35104 Euclid Av, Suite 203, Willoughby, OH 44904 Phone: 440-942-3513 Fax: 440-942-3513 |
Jennifer Giesel, PHD, LICDC-CS Psychologist - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 4212 State Route 306, #100, Willoughby, OH 44094 Phone: 216-831-6611 Fax: 216-456-8128 |
Jeffrey L. Chernin, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 35104 Euclid Ave., Ste. 110, Willoughby, OH 44094 Phone: 440-951-9669 Fax: 440-951-8117 |
Dr. Lori Ann Stevic-rust Psychologist - Health Service Medicare: Accepting Medicare Assignments Practice Location: 4132 Erie St Ste 208, Willoughby, OH 44094 Phone: 440-946-7796 |
Barbara A. Diedrick, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 4212 Ohio State Route 306, Suite 100, Willoughby, OH 44094 Phone: 216-831-6611 Fax: 216-456-8128 |
Dr. Sherry A. Dinner, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5105 Som Center Rd, Willoughby, OH 44094 Phone: 216-621-5600 Fax: 216-479-5554 |
Nancy L. Davidson, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 4212 State Route 306, Suite 306, Willoughby, OH 44094 Phone: 440-942-0100 Fax: 440-942-0104 |
James W. Davidson, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 4212 State Route 306, Suite 306, Willoughby, OH 44094 Phone: 440-942-0100 Fax: 440-942-0104 |
Dr. Lucene Wisniewski, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 35900 Euclid Ave, Laurelwood Hospital, Willoughby, OH 44094 Phone: 440-954-3419 Fax: 440-953-3331 |
Natalie Borrell, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 5000 Shankland Rd, Willoughby, OH 44094 Phone: 440-975-3637 |
Shari Ridge, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 35000 Chardon Rd, 210, Willoughby, OH 44094 Phone: 440-951-5600 Fax: 440-951-1293 |
Mrs. Lauren Clark, ED.S. NCSP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 5339 Chestnut Hill Dr, Willoughby, OH 44094 Phone: 216-287-1142 |
Dr. Stacey Brewster Foerstner, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 34950 Chardon Rd, Suite #202, Willoughby, OH 44094 Phone: 440-510-5100 Fax: 440-510-5151 |
Mrs. Leslie Cuva Mongelluzzi, IMFT Psychologist - Group Psychotherapy Medicare: Not Enrolled in Medicare Practice Location: 35104 Euclid Ave Ste 108, Willoughby, OH 44094 Phone: 440-320-4913 |
Mrs. Ann Grosz Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 37047 Ridge Rd, Willoughby, OH 44094 Phone: 440-975-3697 |
News Archive
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
In a carefully controlled study, Michigan Medicine researchers will kick off the first national trial to study allergic reactions to the COVID-19 mRNA vaccines.
This afternoon the Food and Drug Administration (FDA) Advisory Panel, considering the new "Emergency Contraceptive," Ella, which can also act as an abortifacient, voted against recommending ANY precautions or labeling that would inform women of the drug's abortifacient capabilities as well as health risks.
› Verified 6 days ago